References
Remy DC, Rittle KE, Hunt CA, Anderson PS, Engelhardt EL, Clineschmidt BV et al. (+)- and (−)-3-Methoxycyproheptadine: a comparative evaluation of the antiserotonin, antihistaminic, anticholinergic, and orexigenic properties with cyproheptadine. J Med Chem 1977;20:1681–4.
Itoh Y, Kato H, Koshinaka E, Ogawa N, Nishino H, Sakaguchi J. Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same. Eur Patent No 0 399 414 A1 (1990).
Zhang M-Q, Ter Laak AM, Timmerman H. Structure-activity relationships within a series of analogues of the histamine H1-antagonist terfenadine. Eur J Med Chem 1993;28:165–73.
Casy AF. Antihistamine drugs. In Handbook of Stereoisomers: Therapeutic Drugs. (Ed. Smith DF and Boca Raton FL) pp. 149–164, CRC Press, 1989.
Eglen RM, Reddy H, Watson N, Challiss RAJ. Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol Sci 1994;15:114–9.
Polymeropoulos EE, Kutscher B, Fleischhauer I. Computerassisted analysis of the possible binding sites of H1-antagonists. In QSAR: Rational Approaches to the Design of Bioactive Compounds. (Ed. Silipo C and Vittoria A) pp. 261–264, Elsevier Science Publishers B.V., Amsterdam 1991.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhang, M.Q., Walczynski, K. & Timmerman, H. A steric approach for the design of antihistamines with low muscarinic receptor antagonism. Inflamm Res 44 (Suppl 1), S90–S91 (1995). https://doi.org/10.1007/BF01674411
Issue Date:
DOI: https://doi.org/10.1007/BF01674411